A trade deal has been reached between the US and the European Union ahead of this week’s August 1 deadline. The EU was threatened with 30% tariffs but 15% was settled on, in line with Japan, but significantly higher than the current non-agricultural weighted average around 1%. Euro stoxx futures are up 1.0% in APAC trading outperforming the S&P’s +0.4%. EURUSD’s response has been muted.
- The EU is the second largest source of US imports thus a deal was likely but given the significant rise in import duties is also likely to drive higher US prices. The 2024 US deficit with the EU was $235.9bn, but still less than China’s $295.5bn.
- Exports to the US are important with 16.8% of 2024 extra-euro area goods shipments going there but that was worth only 3.2% of GDP, below the exposure of Canada, Mexico and Taiwan but similar to Japan’s.
Exports to the US (ex NAFTA) 2024 %
Source: MNI - Market News/LSEG
- The EU is the second largest source of US auto imports and Germany is fifth. Shipments will also face 15% tariffs but below the 25% duty against all US vehicle imports.
- Pharmaceuticals will also face 15% but it was threatened with up to 200%. 30% of US pharma imports come from Ireland and 57% from the EA accounting for over a quarter of total EA exports to the US.
- The 50% tariff on US imports of steel and aluminium is unchanged but both sides agreed not to tax aircraft and parts.
- Like others, Europe has frontloaded shipments to the US with them peaking at 60.8% y/y in March and easing to 7.3% y/y in May. Bloomberg data showed container ship departures from the EU-6 at around 100/day in the first week of July but that eased to 70 last week well below the pre-2025 average of 95.
US imports of pharmaceuticals & medicines % total 2024
Source: MNI - Market News/International Trade Administration